Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4abde64a2a4ff6ea75befbbecf72f6d5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7036 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
filingDate |
2018-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dea7b14e935120cef2a3368f66c326d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cc6d6809f46fa1bbfd956dbc38bfb15 |
publicationDate |
2022-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11213537-B2 |
titleOfInvention |
Inhibition of autism spectrum disorder using ribosomal read-through compounds |
abstract |
The present invention relates to the novel use of read-through compounds for use in the treatment and/or prevention of Autism Spectrum Disorder. |
priorityDate |
2017-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |